Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,841,255
-
Number of holders
-
432
-
Total 13F shares, excl. options
-
82,484,516
-
Shares change
-
-4,100,612
-
Total reported value, excl. options
-
$7,660,607,605
-
Value change
-
-$373,404,549
-
Put/Call ratio
-
71.8%
-
Number of buys
-
219
-
Number of sells
-
-163
-
Price
-
$92.86
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2016
468 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2016.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 432 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82,484,516 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (6,703,403 shares), BAMCO INC /NY/ (6,584,973 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,531,897 shares), Fundsmith LLP (4,469,336 shares), BlackRock Fund Advisors (3,545,865 shares), BlackRock Institutional Trust Company, N.A. (3,268,627 shares), Select Equity Group, L.P. (2,907,917 shares), STATE STREET CORP (2,770,661 shares), Neuberger Berman Group LLC (2,663,679 shares), and ATLANTA CAPITAL MANAGEMENT CO L L C (2,505,517 shares).
This table shows the top 432 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.